Gold Coast Refining rebrands as GC Lipids

This post was originally published on this site

CHATTANOOGA, TN – 02-12-2019 (PRDistribution.com) — Gold Coast Refining has adopted a new name—GC Lipids, LLC—in order to communicate the company’s mission and products more effectively. “The change in name reflects our focus on the growing demand for high-quality, affordable specialty fats and oils in the feed, food, and industrial markets,” says Mark Mauss, President of GC Lipids.GC Lipids offers a range of products and services, including nutritional lipids, encapsulated nutrients, waxes, hydrogenated fats, vegetable oil refining and toll manufacturing. GC Lipids offers alternatives to petroleum products for industrial applications.

 

In response to customer requests for purity and precision, GC Lipids has spent the last few years developing its manufacturing capabilities and its safety and quality programs. The company will soon be registered as a kosher, non-GMO and organic processor. The company is pursuing safety certification through the Global Food Safety Initiative. 

 

GC Lipids is a joint venture of Gold Coast Commodities in Brandon, MS, and LUTROS, LLC in Chattanooga, TN. Gold Coast Commodities has been serving the feed and industrial fat and oil markets for 35 years. LUTROS, LLC, an engineering and technology-licensing company, has served the feed, specialty chemical and biodiesel industries with innovative and patented process solutions for 12 years.

 

Please learn more at www.gclipids.com, or contact

Mark Mauss

+1.423.702.4414

[email protected]

Media Contacts:

Company Name: GC Lipids
Full Name: Mark Mauss
Phone: 4237024414
Email Address: Send Email
Website: www.gclipids.com

For the original news story, please visit https://prdistribution.com/news/gold-coast-refining-rebrands-as-gc-lipids.html.

Recommended For You

mm

About the Author: Sidney Martin

Sidney Marin Is a researcher and law student at York University (TORONTO). He has worked as the Director of the Graduate Lawyering Program. He worked for American law firms in Moscow, Russia for three years. Hegraduated from Columbia Law School, Columbia School of International and Public Affairs and Harvard College. He research interest is in human rights and health law, with a particular focus on the law and policy of vaccination.